Chronic Kidney Disease Clinical Trials in Ann Arbor, Michigan

4 studies are recruiting for chronic kidney disease in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

    This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medicine called empagliflozin helps children and adolescents with CKD. Other goals of the study are to find out how empagliflozin is tolerated and handled by the body in chil…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    93 in total
    Run by
    Boehringer Ingelheim

    See if you can join NCT07107945 on ClinicalTrials.gov

  2. A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

    This study will evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses (SAD) and multiple ascending doses (MAD) of AZD4248 administered as an oral solution and intravenous (IV) infusion. Additionally, the study investigates the non-interventional f…

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Research Site, Ann Arbor, Michigan
    Locations
    5 in total
    Run by
    AstraZeneca

    See if you can join NCT07024823 on ClinicalTrials.gov

  3. University of Michigan "Nephrology Research BioBank"

    The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.

    Stage
    Not phased
    Ages
    Any age
    Site
    University of Michigan Health System, Ann Arbor, Michigan
    Run by
    University of Michigan

    See if you can join NCT00381121 on ClinicalTrials.gov

  4. Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

    Chronic kidney disease (CKD) affects approximately 26 million Americans and disproportionately manifests in specific race and ethnic groups. Patients burdened with CKD have significant morbidity and reduced life expectancy. In addition to excessive suffering and lost productivity, the cost of manag…

    Stage
    Not phased
    Ages
    Any age
    Site
    University of Michigan Health System, Ann Arbor, Michigan
    Locations
    5 in total
    Run by
    University of Michigan

    See if you can join NCT01016613 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.